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Abstract. GLUTI, the erythrocyte glucose transporter,
and GLUT4, the adipose/muscle transporter, were
each expressed in NIH-3T3 cells by retrovirus-medi-
ated gene transfer. In fibroblasts overexpressing
GLUT1, basal as well as insulin-stimulated deoxyglu-
cose uptake was increased. Expression of GLUT4 was
without affect on either basal or hormone stimulated
hexose uptake. Localization of each ofthe transporters
by indirect immunofluorescence revealed that, whereas
GLUTI was found primarily on the cell surface,
GLUT4 was directed to vesicles in a perinuclear dis-
tribution and throughout the cytoplasm. The GLUT4-
containing compartment represented neither Golgi
complex nor lysosomes, as evidenced by the failure of
1gp110 or Golgi mannosidase to co-localize. However,
ONE of the best-characterized actions of the anabolic
hormone insulin is its ability to rapidly and reversi-
bly increase the rate of glucose metabolism in pe
ripheral target tissues (8). The flux of sugars across the
plasma membrane ofmammaliancells iscatalyzedbya class
of integral membrane glycoproteins, the facilitated hexose
transporters. It is this process which is the primary site of
action bywhichinsulinmodulates glucoseuptake.A number
ofyears ago, itbecame clearthatin thebasal stateasubstan-
tial number of glucose transporters in adipose tissue and
probably muscle reside within thecell, wherethey areinac-
tive presumably solely becauseoftheirinaccessibility to ex-
tracellularsugars (36). Shortly afterexposure to insulin, the
adipose cell redistributes its glucose transporters such that
a greaternumber are located on thecell surfaceand contrib-
ute to the influx of hexoses. Whereas it remains unclear as
to whether the "translocation" model explains all of the
increase in hexose uptake in response to hormone, redistri-
bution certainly occurs and is important to the overall
augmented glucose flux. Therefore, a major part of under-
standing the mechanism by which insulin regulates hexose
metabolism involves characterizing the pathways ofsubcel-
lular trafficking of glucose transport proteins.
Recently, the existence ofa gene family encoding related
glucose transport proteins has been firmly established (4).
The two isoforms relevant to the experiments discussed be-
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there was substantial overlap between the distribution
of GLUT4 and the transferrin receptor, and some co-
localization of the transporter isoform with the man-
nose-6-phosphate receptor. In addition, when FITC-
wheat germ agglutinin bound to the cell surface was
allowed to internalize at 37°C, it concentrated in ve-
sicular structures coincident with GLUT4 immunore-
activity.
These data establish that GLUTI and GLUT4 con-
tain within their amino acid sequences information
which dictates targeting to distinct cellular compart-
ments. Moreover, GLUT4 can be recognized by those
cellular factors which direct membrane proteins to the
endosomal pathway.
low are GLUTI and GLUT4. cDNAs encoding the former
were originally cloned from human hepatoma andratbrain,
and probably also code for the well-characterized human
erythrocyte hexose carrier (6, 32). Whereas GLUTI is ex-
pressed fairly ubiquitously in adult mammalian tissues,
GLUT4 is found exclusively in adipose tissue, muscle, and
heart, those organs most responsive to insulin in terms of
hexose uptake (5, 8, 24). Thesedatahave ledtotheideathat
theexpression ofGLUT4 isanessential requirementfor the
full, hormonal stimulation. Consistent with this model, in-
sulineffectsagreaterincreaseinGLUT4 thanGLUTI in the
plasma membrane ofadipocytes, though both are recruited
to some extent (5, 23, 24). Theprecise contribution ofeach
ofthe isoforms to the actual flux ofhexose in thebasal and
insulin-stimulated states remains undetermined. In addition,
the subcellular pathways through which each ofthe trans-
porters is routed in the adipocyte are ill defined.
The majorhypothesis whichformsthebasis forthestudies
reported herein is that each of the transporters contains in-
trinsic to its primary structure information dictating target-
ing to distinct cellular compartments. Our strategy to test
this model has been to introduce the two isoforms into the
same cellular context and examine the subcellular distribu-
tions and transport activity. In addition, we have addressed
the question ofwhether expression ofGLUT4 is sufficient
to confer full insulin-responsive transport.
785Materials andMethods
Materials
2-[I,2-3H]-deoxy-D-glucose (30.2 Ci/mmol) was purchased from New En-
gland Nuclear (Boston, MA), 31STranslabel and "'I-protein A (>30
mCi/mg) were from ICN Radiochemicals (Irvine, CA). FIX and rhoda-
mine-conjugated antibodies were purchased from Tago (Burlingame, CA),
FITC-conjugated wheat germ agglutinin (WGA)' was from Molecular
Probes (Eugene, OR), endoglycosidase H from Boehringer-Mannheim Bio-
chemicals (Indianapolis, IN), SP6 RNA polymerase from New England
Biolabs (Beverly, MA), Geneticin (G418) and Lipofectin reagent from
Gibco-BRL (Gaithersburg, MD), and thebicinchronic proteinassay kit was
purchased from Pierce Chemical Co. (Rockford, IL). Insulin was a gift
from Dr. Ronald Chance ofLilly Laboratories (Indianapolis, IN). All other
chemicals were purchased from Sigma Chemical Co. (St. Louis, MO).
Antiseradirectedagainstthe transferrin receptor, 1gpl10, Golgi mannosi-
dase II, and the mannose-6-phosphate receptor were generously provided
by Roger Davis (University of Massachusetts, Worcester, MA), Bruce
Granger (Yale University School of Medicine, New Haven, CT), Brian
Burke (Harvard Medical School, Boston, MA), and Thomas Braulke
(GeorgAugust-Universitat G6ttingen, G6ttingen, Germany), respectively.
Affinity purified anti-GLUTI antipeptide antisera for immunofluorescence
was a gift of Bernard Thorens (MIT, Cambridge, MA).
DNA Constructs
The rat GLUT4 glucose transporter cDNA was isolated by excision from
the plasmid pSMl-1-1 (5) by first digesting with Xbal, filling in the ends
using the Klenow fragment ofDNA'polymerase I, adding Sall linkers, and
re-ligating the plasmid. The resultant plasntid was digested with AhaHI,
BamHI linkers were added, and the plasndd was religated. The resulting
1.8-kb BamHI-Sall fragment, containing the GLUT4 cDNA coding region
as well as 12 and 272 by of 5-prime and 3-prime flanking DNA, respec-
tively, was ligated into the multiple cloning site ofpDO-R, andcalled pDOJ-
SM. The retroviral expression vector, pDO-R, which was kindly provided
by Dr. Connie Cepko (HarvardMedical School, Boston, MA) contains sites
for insertion of a cloned cDNA immediately downstream of the retraviral
LTR, as well as a neomycin resistance gene driven by the SV-40 early pro-
moter, which allows selection of transfected cells by growth in media con-
taining the antibiotic G418 (31). A retroviral expression plasmid containing
the rat GLUTI cDNA, pDOJ-GT, was constructed from a fragment of the
GLUTI cDNA (6) extending from the unique Xhol site (changed to a BglII
site) to the natural BglII site; this insert contains the complete coding region
as well as 17 and 97 by of 5-prime and 3-prime non-translated sequences,
respectively.
To construct a vector suitable for the expression of a cloned cDNA by
a strong promoter using histidinol for positive selection, pCMV1 (provided
by Dr. M. F. Stinski, University of Iowa, Iowa City, IA), which contains
a cytomegalovirus promoter followed bya human growth hormone termina-
tion sequence, was used (1). The EcoRl site in the polylinker wasdestroyed,
and the remaining EcoRI-Sfil fragment isolated and ligated to the EcoRl-
Sfil fragment of pSV2-His, which contains the h1sD gene of Salmonella
typhimurium, encoding histidinol dehydrogenase (21). The fragment of the
rat GLUT4 cDNA described above was cloned into the polylinker following
the CMV promoter using the unique BglII restriction site.
Cell Culture and Gene Ransfer
NIH-3T3 fibroblasts and 02 cells were grown in DME supplemented with
10% calf serum in an atmosphere of 8% COZ at 37°C. Cells transfected or
infected with vectors encoding neo resistance were grown in the same
medium supplemented with 400 ug/ml G418 (active concentration); for
cells expressing histidinol resistance, 400mg/ml histidinol was added to the
media.
The retroviral packaging cell line ~2 (29), obtained from C. Cepko (Har-
vard Medical School), was transfected with either pDOJ-SM, pDOJ-GT, or
pDOJ using the Lipofectin reagent as suggested by the manufacturer. After
selection in medium containing 400 pg/ml G418, the clones were expanded
and screened for retrovirus. Clones were grown to over-confluence, the
virus-containing medium was harvested and polybrene (8 ug/ml) was
added, and this medium used to infect NIH-3T3 fibroblasts. After 3 h, fresh
medium was added to dilute the polybrene to 2 pg/ml and the cells were
1. Abbreviation used in this paper: WGA, wheat germ agglutinin.
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allowed to divide twice before they were split 1:20 into selection medium
containing400,ug/ml G418 (active concentration). Colonies wereobserved
10-14 d after selection. These were pooled or cloned, and continued to be
grown in medium containing 400 ug/ml G418. NRK cells expressing
GLUT4 were made by lipofectin-mediated gene transfer of pDOJ-SM
DNA.
NIH-3T3 HIR3.5 and CHO HIRC cell lines were graciously provided by
Drs. Jonathan Whittaker (State University ofNew York, Stony Brook, NY)
and Morris White (Joslin Diabetes Center, Boston, MA), respectively.
Analysis ofProteins
Crude total cellular membranes were prepared and assayed for glucose
transporter content by SDS-PAGE and Western blot analysis as described
(22). Rabbit polyclonal antisera raised against bacterial fusion proteins in-
cluding the cytoplasmic carboxy terminus of GLUT4 have been described
(5), and rabbit anti-GLUTI polyclonal antibodies purchased from East
Acres (Southbridge, MA) were used for Western blotting at a dilution of
1:2,000.
For the determination of sensitivity to endoglycosidase H, cells plated
on 10-cm dishes (GLUT4) or 6-well dishes (GLUTI) and grown to
confluence were washed with PBS and incubated in methionine-free DME
(Gibco-BRL) for 45 min. They were exposed to 35S-Translabel (0.5
mCi/ml) in DME with 2.5% BSAfor 15 minand chased with DME contain-
ing 0.2 mg/ml methionine and 0.2 mg/ml cysteine. The chase was termi-
nated by placing the cells on ice and washing with cold PBS. For GLUTI,
the cells were solubilized directly and used for immunoprecipitation . For
GLUT4, crude membranes were prepared from each plate (22). Membrane
pellets were resuspended in solubilization buffer (50 mM Tris, pH 7.4, 100
mM NaCl, 1 mM DTT, 0.4% SDS, 1 mM PMSF) and immunoprecipitation
with GLUT4 was carried out (5). The protein A-Sepharose pellets were
resuspended in 0.05% SDS, and boiled for 4 min. The enzymatic reaction
was carried out inthe presence of 50mM sodium citrate, 10pg/ml protease
inhibitors (chymostatin, leupeptin, antipain, pepstatin, and PMSF), and
2 mU endoglycosidase H for 17 h at 37°C. After digestion, the samples
were submitted to 10% SDS-PAGE, treated with Enhance (New England
Nuclear), andexposed to KodakXAR-5 film(Eastman KodakCo., Roches-
ter, NY) at -70°C.
For quantitation of transporter isoforms by Western immunoblot, stan-
dards were prepared. These consisted ofS-galactosidase fused to the cyto-
plasmic carboxy terminus of each of the transportes. The construction of
the/3-galactosidase-GLUT4 fusion protein hasbeen described (5). For con-
struction of the GLUTI fusion protein, the lacz-containing plasmid,
pUR291 (35), was digested with BamHI, the staggered ends filled in with
the Klenow fragment ofDNA polymerase I, and the plasmid digested with
Pstl. The 625-bp fragment of a Rsal/Pstl digest of the rat GLUTI cDNA
was isolated and ligated into pUR291. This resulted ina construct encoding
the terminal 51 amino acids of the rat GLUTI protein fused in frame to
,B-galactosidase. Both fusion proteins were partially purified from Esche-
richia coli inclusion bodies by extraction with 6 M urea and l3-mercapto-
ethanol (5), and quantitated by SDS-polyacrylamide electrophoresis fol-
lowed by staining with Coomassie blue using 0-galactosidase as a standard.
Hexose T}ansport
The rate of hexose transport was determined by measuring the uptake of
2-deoxy-D-[3H]glucose (15). Varying concentrations ofinsulin were added
for the last 20 min of incubation. Uptake was initiated by the addition of
0.1 ml KRP containing 1 or 2 mCi/m12-deoxy-D-[3H]glucose and 0.5 mM
or 1.0 mM deoxyglucose. After 4 min, during which time the uptake was
linear, the reaction was stopped by three successive immersions ofthe plate
into ice-cold TBS (154 mM NaCl, 20 mM Tris, pH 7.4) . The cells were
solubilized in0.75 ml l% TritonX-100 for 20minat 37°C, and radioactivity
determined in a 0.5-ml aliquot by liquid scintillation spectrometry. Uptake
was measured in duplicate. The protein concentration of the solubilized
cells was determined using the bicinchronic assay (Pierce Chemical Co.),
with BSA as a standard.
Immunofluorescence
Cells plated on glass coverslips 2 d before an experiment were washed with
PBS and fixed in 3 % paraformaldehyde for immunofluorescence (15). For
the immunofluorescent localization of the transferrin receptor, cells were
permeabilized with 0.1% NP-40 instead of Triton X-100. For detection of
lgpll0, fixation was accomplished by immersion in ice cold methanol for
5 min, followed by acetone for 30 s. In all cases, coverslips were mounted
786in Mowiol and visualized with an Axiophot fluorescence microscope (Carl
Zeiss, Oberkochen, Germany) .
For endocytosis studies, JSM8 cells wereplated onto glass coverslips 2 d
before an experiment . The coverslips were transferred to 6-well dishes con-
taining L15 (Gibco-BRL) media with 2 % calf serum and 5 pg/ml FITC-
conjugatedWGA (FTICWGA) at 4°C for 1 h . The cells were washed three
times with coldL15 media, and then transferred to a 6-well plate containing
L15 media plus 2% calfserum at 37°C for the times indicated . The uptake
was terminated by return of the cells to L15 with 2% calf serum at 4°C,
followed by washing of the cells twice with cold PBS containing 50 MM
N-acetyl glucosamine. These washes removed most, but not all of the ex-
tracellular bound FTTCWGA . The cells were then fixed and processed for
immunofluorescence as described above .
Expression in Xenopus Oocytes
GLUTI and GLUT4RNA were synthesized in vitro and injected into oo-
cytes prepared from gravid Xenopus laevis frogs (Xenopus I, WI) as has
been described (5, 30) . Hexose transport assays were performed 3 d after
injection .
Results
'Itivo glucose transporter retroviral expression vectors, pDOJ-
GT (GLUTI) and pDOJ-SM (GLUT4) were constructed
using the plasmid pDO-R, in which the viral long terminal
repeat serves as promoter for inserted cDNAs (31) . Stable
cell lines were established by transfection of the retroviral
packaging cell line ~2 followed by infection ofNIH-3T3 cells
with the viral supernatant . A control cell line, DOJ, was
generated by infection ofNIH-3T3 cells with parental virus .
Colonies were selected in G418, and both pooled and clonal
cell lines established . Overexpression of the transportrtes
was analyzed by Western blot ofGLUT1 and GLUT4 using
polyclonal antisera directed against the carboxy terminus of
each protein . GLUT4 was not detected in total membranes
prepared fromNIH-3T3 infected with parental virus (DOJ),
but was present as a single immunoreactive species in mem-
branes from a pool of G418-resistant cells infected with
DOJ-SM (Fig . 1) . On the other hand, GLUTI was readily
detected in DOJ membranes ; the amount of GLUTI was
significantly greater in membranes from DOJ-GT infectant
cells . For the interpretation of experiments described below,
it was essential to ascertain the relative levels of overexpres-
sion and expression of GLUTI and GLUT4, respectively.
Since different antisera were used for immuno-detection of
the transporter isoforms, a simple comparison of the West-
ern blots was not adequate . Instead, standards were pre-
pared ; these consisted of the cytoplasmic "tails" of each of
the proteins fused to a-galactosidase, expressed in E. coli,
and partially purified . This method provided a means of
comparing the relative affinities of the non-crossreactive an-
tisera for GLUTI and GLUT4 . Total membranes from two
clonal lines ofNIH-3T3 cells expressing GLUT4 (JSM8) or
overexpressing GLUTI (JGT2) were submitted to Western
immunoblot analysis along with the several known amounts
of a-galactosidase-glucose transporter fusion proteins .
Quantitation of the radioactivity in each band indicated that
theJGT2 clone ofDOJ-GT infected NIH-3T3 fibroblasts ex-
pressed about 16-fold more GLUT1 than the parental cells .
A cell line (JSM8) derived from DOJ-SM infected fibro-
blasts expressed approximately threefold higher levels of to-
tal cellular GLUT4 than GLUTI (data not shown) .
The biochemical effects of overexpression of each trans-
porter isoform in these cell lines were examined using 2-de-
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Figure 1. Westem immunoblot of glucose transporter isoforms in
NIH-3T3 fibroblasts. 40 p,g total membranes prepared from pools
ofG418-resistant fibroblasts infected withDOJ, DOJ-SM (GLUT4),
or DOJ-GT (GLU77) recombinant retrovirus were submitted to
SDS-polyacrylamide electrophoresis, transferred to nitrocellulose,
and probed by polyclonal antisera specific for GLUT4 (A) or
GLUT1 (B) . The samples inA represent duplicate preparations of
membranes. Sizes oftwo molecular weight standards are indicated
inM
oxyglucose uptake in the presence ofincreasing insulin con-
centrations . Basal levels of glucose uptake in JGT2 cells
were approximately seven times greater than in control cell
line, DOJ (Fig . 2) . Furthermore, insulin-stimulated hexose
uptake significantly ; the magnitude of the increase was
greater, but the fold stimulation less than in parental fibro-
blasts . There was no significant difference in the rates ofhex-
ose uptake between the GLUT4 expressing JSM8 cells and
control fibroblasts when the assay was performed in the ab-
sence or in the presence of several concentrations of insulin
(Fig. 2) . Apparent minor differences in transport between
DOJ and JSM8 in the series of experiments represented in
Fig . 2 were not supported by study of other independently
isolated cell lines (for example see Fig . 4) . Hexose uptake
in clonal or pooled fibroblast cell lines infected with DOJ-
GT in which the level ofGLUTI was increased only two- to
fourfold demonstrated a commensurate increase in hexose
uptake (data not shown) . This is similar to results reported
by other investigators following introduction ofGLUT1 into
other fibroblast cell lines (2, 19, 20) .
One trivial explanation for the lack ofincreased hexose up-
take in JSM8 cells in spite of the overexpression ofGLUT4
was that the GLUT4 cDNA had sustained an inactivating
mutation in the course of molecular cloning . To exclude
this possibility, mRNA was synthesized in vitro from the
clonedGLUTI and GLUT4cDNAs and injected into Xeno-
pus laetis oocytes . Oocytes injected with either transporter
mRNA catalyzed significantly more 2-deoxyglucose uptake
than water injected oocytes, and uptake in GLUTl-
expressing oocytes was about 1.5-fold greater than that in
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Figure 2 . Hexose uptake into glucose transporter expressing NIH-
3T3 fibroblasts . 2-Deoxyglucose uptake into clonal lines of fibro-
blasts expressing vector alone (o), GLUTI (JGT2, o) andGLUT4
(JSM8,m) was measured in the presence of varying concentrations
of insulin. Values are the means t SEM of four experiments, per-
formed in duplicate .
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Figure 3 Uptake of hexose into Xenopus laevis oocytes . Oocytes
injected with HZO (o) or 50 ng mRNA encoding GLUTI (m) or
GLUT4 (o) were incubated for 3 d at 19°C before assay for 2-de-
oxyglucose uptake as a function of time . Each point represents the
mean of5 oocytes, and is typical ofat least four independent experi-
ments .
GLUT4 (Fig . 3) . These data indicate that both cDNAs are
capable of encoding catalytically active hexose transport
proteins and are consistent with previous reports of expres-
sion in oocytes (5, 16, 27, 41) .
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Figure 4. Hexose uptake into fibroblasts overexpressing insulin
receptors and GLUT4 . NIH-3T3 HIR3.5 cells orCHO HIRC cells
overexpressing human insulin receptors were transfected with a
plasmid encoding ratGLUT4 . Clonal cell lines expressingGLUT4
protein were identified by immunofluorescence, grown to mass cul-
ture, and assayed for 2-deoxyglucose uptake in the absence (®) and
presence (m) of 1 )M insulin . For each parental fibroblast line,
uptake data from a control cell line as well as two independently
isolated GLUT4 expressing clones are shown .
Another explanation for the inability of overexpression of
the GLUT4 isoform to alter hexose uptake could have been
that fibroblasts lack sufficient number of insulin receptors to
stimulate recruitment of transporters to the cell surface . To
test this possibility, GLUT4 was introduced into fibroblast
lines already expressing high numbers of functional human
insulin receptors by DNA-mediated gene transfer. The rat
GLUT4 cDNA was cloned into an eucaryotic expression
vector with the following characteristics : transcription ofthe
transporter cDNA was driven by the strong CMV promoter,
since preliminary experiments had shown that this achieved
higher levels ofGLUT4 protein than either the viral LTR or
the SV-40 early promoter ; and the plasmid contains the hisD
gene ofSalmonella typhimurium, encoding resistance to his-
tidinol and thus permitting introduction of a second cloned
gene into cells already G418 resistant . Two such cell lines
were used for this purpose, NIH-3T3 HIR3.5 cells andCHO
HIRC cells (42, 43) . Fig . 4 shows deoxyglucose uptake into
control cells (vector alone) and two independent clonal cell
populations of either CHO HIRC or NIH-3T3 HIR3.5 cells
which express rat GLUT4 in addition to human insulin
receptors . Even in the presence of insulin receptors, the ex-
pression ofGLUT4 did not augment the increase in hexose
uptake in response to hormone .
To clarify the mechanism underlying the differential effect
on hexose uptake inGLUTI vs . GLUT4 expressing cells, the
intracellular localization ofeach transporter isoform was ex-
amined by indirect immunofluorescence . Pools of NIH-31`3
cells infected with DOJ-GT displayed increased expression
of GLUT1 in >90% of the cells . In essentially all overex-
Figure S. Immunofluorescent localization of glucose transporter isoforms in 3T3-L1 fibroblasts . (a) . Fibroblasts overexpressing GLUTI
(NIH-JGT) or GLUT4 (NIH-JSM) were assayed for the distribution of transporter using antisera directed againstGLUTI (left) orGLUT4
(right) . Phase micrographs ofthe corresponding fields are shown below. For GLUTI, a non-expressing cell can be visualized in the upper
part of the micrograph, and several non-expressing cells are seen in the lower part of the panel containing the DOJ-SM-infected cells .
Bar, 20,um.Hudson et al . Glucose Transporter Subcellular Targeting
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789pressing cells as well as parental fibroblasts, GLUTI ap-
peared to be substantially on the cell surface (Fig . 5) . There
was some perinuclear staining in most of the GLUT1-
overexpressing cells (data not shown) . The general subcellu-
lar distribution ofGLUTI appeared to be independent of the
level of expression in each of the individual infected cells .
The cellular location of GLUT4 was strikingly different .
This transporter isoform was detected predominantly in a
perinuclear region in a distinctly punctate distribution (Fig .
5) . GLUT4 was also distributed throughout the cell, again
in a punctate pattern . Whereas the intensity of the more pe-
ripheral GLUT4 immunofluorescence was somewhat vari-
able among different experiments (for example compare
Figs. 5 and 10), the general pattern of staining was relatively
independent of the level of expression . However, the highest
expressing cells in the mixedpolyclonal population often dis-
played some cell surface staining .
We sought evidence as to whether the distribution of
GLUT4 was a result of the foreign protein being arrested in
a biosynthetic compartment . Acquisition of resistance to
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Figure 6. Acquisition ofresistance to endoglycosi-
dase H . Fibroblasts infected with recombinant
retroviruses were labeled with 'SS-Translabel for
15 min, incubated with non-radioactive amino
acids for the times indicated, immunoprecipitated
and treated with endoglycosidase H . Molecular
weight standards are shown in kD. The approxi-
mate mobility of the mature transporter is indi-
cated by an arrow, and the earliest synthesized
precursor by an open arrow. (a) Fibroblasts ex-
pressing GLUTI, immunoprecipitated with an an-
tisera against this isoform . Immunoadsorption of
extract from the 60 min chased cells to protein
ASepharose in the absence of antisera is shown
(NoAb) . (b) Fibroblasts expressing GLUT4, im-
munoprecipitated with an antisera against this iso-
form . Immunoadsorption ofextract from the "non-
chase" cells to protein ASepharose in the absence
of antisera is shown (No Ab) .
digestion by endoglycosidase H is a characteristic feature of
a glycoprotein which has undergone processing in the cis-
and middle Golgi complex . Fibroblasts expressing either rat
GLUTI or GLUT4 were metabolically labeled for 15 min,
and then "chased" with non-radioactive amino acids as indi-
cated . At each time, transporter was immunoprecipitated,
and half of the carrier enzymatically deglycosylated by
digestion with endoglycosidaseH . Fig . 6 A shows the acqui-
sition of resistance to endoglycosidase H in GLUTI overex-
pressing cells . By the end ofthe labeling period, much ofthe
GLUTI was already resistant to endoglycosidase H, and the
remainder of the transporter acquired resistance in the sub-
sequent 10 min . Asshown in Fig . 6 B,GLUT4 was processed
considerably more slowly, requiring 30 min to acquire com-
plete resistance to endoglycosidase H . In addition, it ap-
peared that the amount ofGLUT4 protein decreased during
the course of the experiment, suggesting that some of the
GLUT4 protein may have been degraded before complete
maturation . Nonetheless, these data demonstrate that for-
eign GLUT4 does ultimately acquire resistance to en-
790doglycosidase H in murine fibroblasts, and thus traverses the
medial Golgi complex .
In view of the relatively slow posttranslational processing
ofGLUT4 protein, further studies were performed to deter-
mine whether the steady state GLUT4 staining pattern
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Figure 7 . Immuno-localization of the Golgi complex andGLUT4 .
Pools ofNRK fibroblasts stably expressing ratGLUT4 were stained
with antisera againstGLUT4 (left) and Golgi mannosidase II (right) .
The corresponding phase micrograph is shown on the bottom . Bar,
20 ttm .
reflects transient accumulation in the Golgi complex . AmAb
directed against rat Golgi mannosidase II was used to iden-
tify the Golgi complex in double labeling experiments (3, 7) .
Since the a-Golgi antibody is specific for rat cells, GLUT4
was stably expressed in NRK fibroblasts . The same cells
79 1were labeled with ci-GLUT4 polyclonal sera and a-Golgi
mannosidase mAb, and visualized with rhodamine- and
FITC-conjugated secondary antibodies, respectively (Fig .
7) . Whereas both antigens were located in the same region
of the cell, they clearly resided in distinct subcellular struc-
tures. Double-exposure color photomicrographs indicated
that the GLUT4 protein was present in punctate structures
interspersed amongst the Golgi complex (data not shown) .
Another explanation for the differential subcellular distri-
bution ofGLUTI andGLUT4 might have been that the latter
was being targeted to a degradative pathway. To address this,
immunofluorescent co-localization was performed using
1gp110, a marker for lysozomes (17) . As can be seen in Fig .
8, in pools of NIH-3T3 cells infected withDOJ-SM, antisera
directed against GLUT4 and 1gp110 detect markedly differ-
ent labeling patterns in the same cells . Though it is possible
thatGLUT4 rapidly lost immunoreactivity after entering the
lysozomes, it is unlikely since the epitope is directed towards
the cytoplasmic surface of the transporter protein .
The data presented thus far indicate that GLUT1 is tar-
geted predominantly to the plasma membrane, but GLUT4
is directed to an intracellular location . A candidate for such
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Figure 8 . Immuno-localization of lysosomes and
GLUT4. Pools ofDOJ-SM cells were stained with
antisera against GLUT4 (top) or 1gp110 (bottom) .
Bar, 20 um .
an intracellular structure is the endocytic compartment. To
address this possibility, experiments were carried out using
antisera directed against the transferrin receptor and the
mannose 6-phosphate receptor, markers for early and late
endosomes, respectively (38) . As shown in Fig . 9 A, the in-
tracellular distributions ofGLUT4 and transferrin receptor
are almost superimposable. Virtually all vesicles containing
GLUT4 also react with antisera directed against the transfer-
rin receptor. There is alsosome overlap in subcellular distri-
bution between GLUT4 and the mannose-6-phosphate re-
ceptor, though this is not as striking as the co-localization
with the transferrin receptor (Fig . 9 B) . In particular, the
more peripherally located GLUT4 lacked coincident man-
nose-6-phosphate receptor immunoreactivity .
Another experiment was performed to independently con-
firm the presence of GLUT4 in the endosomal pathway.
JSM8 cells were incubated with FITCWGA at4°C to label
the cell surface . The unbound lectin was removed, and the
cells warmed to 37°C for the times indicated in Fig . 10 A .
The presence ofFITCWGA did not alter the overall steady-
state distribution ofGLUT4 as ascertained by immunofluo-
rescence microscopy. In the absence of incubation at 37°C,
792Figure 9. Co-localization ofendosomes andGLUT4 . Pools ofDOJ-SM cells were stained with antisera againstGLUT4 (left) and transferrin
receptor (upper right) or the mannose-6-phosphate receptor (lower right) . Bar, 20 Am .
there was a modest amount ofdetectable FITCWGA, and all
was localized on the extracellular surface of the fibroblasts
(Fig. 10 A, 0 min) . By 2.5 min, someFITCWGA was inter-
nalized and present in peripherally disposed vesicular struc-
tures. Importantly, GLUT4 co-localized with the FITC-
WGA . This is shown in more detail in Fig . 10 B, which is
a greater magnification of a single JSM8 cell allowed to take
up FITCWGA for 2.5 min . Note the striking overlap be-
tween the distribution ofGLUT4 andWGA . Allowing the in-
ternalization of FITCWGA to proceed for longer periods of
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time resulted in the progressive labeling ofmore centrally lo-
cated structures (Fig . 10 A) . However, at each time point,
some of the GLUT4 co-localized with the WGA .
Discussion
In the experiments described above, we set out to address
several questions relevant to an understanding of the regula-
tion of glucose transport by insulin : (a) Do GLUTI and
GLUT4 contain within their primary amino acids sequences
793Figure 10 . Endocytosis ofWGA. JSM8 cells were allowed to bind FITCWGA at 4°C and then incubated at 37°C in the absence of lectin
for the times indicated (a) or for 2.5 min (b) . Immunostaining with a-GLUT4 is shown in the upper panel in a, and on the left in b . In
each pair of photomicrographs, the arrows indicate corresponding locations. Bars : (a) 20 gym ; (b) 10 pm .
targeting information which directs each isoform to a distinct
subcellular locale? ; (b) Is the tissue-specific expression of
the GLUT4 isoform sufficient to explain the marked dispar-
ity among cell types in their ability to respond to insulin with
increased hexose uptake? ; and (c) What is the subcellular
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distribution of GLUT4 when expressed in an undifferen-
tiated cell type, and can this pattern be useful in inferring in-
formation concerning the normal pathways of GLUT4 traf-
ficking in adipose and muscle cells?
A number ofyears ago, several groups independently pro-
794Figure 10.
posed that the mechanism by which insulin increased glu-
cose transport was by effecting the rapid and reversible redis-
tribution of hexose carriers from a latent intracellular pool
to the plasma membrane (12, 40) . This model, which has
gathered increasing support over the past ten years, has
placed the problem ofhormone-regulated transport squarely
within the realm of the control of membrane protein
trafficking . Recently, with the recognition ofa true gene fam-
ily of facilitated glucose transporter proteins, it has become
clear that insulin-responsive tissues express a distinct hexose
carrier, GLUT4 (5, 10, 14, 24, 26) . It is thus a very appealing
hypothesis thatthis isoform is uniquely capable of conferring
insulin-regulatable glucose transport and, moreover, that a
distinctive route of cellular trafficking is responsible for this
property . Clearly, in rat adipose cells, a much greater
proportion of GLUTI as compared to GLUT4 resides in
plasma membranes relative to intracellular compartments in
the basal state, and the fold increase in plasma membrane
transporter in response to insulin is greater for GLUT4 (5,
23, 44) . These observations provide some evidence for
differential cellular trafficking of the two isoforms, but do not
address the issue oftheirprecise intracellular compartments .
In particular, data regarding the intracellular co-localization
ofGLUTI and GLUT4 are a bit confusing. Immunoadsorp-
tion of GLUT4-containing vesicles from isolated rat adipo-
cytes has been reported to exclude GLUTI (44) ; however,
since GLUT4 is expressed at approximately 20-fold higher
levels thanGLUTI in rat fat cells, the differential distribution
might be related to level of expression . In 3T3-Ll adipo-
cytes, in which GLUTI is present at levels 3.5- to 5-fold
greater than GLUT4, immunopurification of vesicles by im-
mobilized a-GLUT4 has been alternatively reported to re-
sult in co-adsorption of some or most of the intracellular
GLUTI (9, 33) . Most recently, Piper et al . (1991) have
presented immunofluorescent localization data of hexose
carriers in 3T3-L1 adipocytes indicating that GLUTI and
GLUT4 reside in distinct subcellular compartments (33) .
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In the current experiments, we have elected to approach
the problem by a different strategy, that is, to use retrovirus-
mediated gene transfer to expressGLUTI andGLUT4 under
similar conditions, and characterize their subcellular distri-
butions . In this way, differences in cellular trafficking would
have to be attributable to information residing in the cloned
cDNAs and the isoforms they encode, since expression is
driven off the same promoter in identical cellular contexts .
Two observations indicate that the transporters are recog-
nized by cellular trafficking pathways in distinct ways : only
GLUTI appreciably alters basal hexose uptake, and the dis-
tributions as ascertained by indirect immunofluorescence are
distinct (Figs . 2 and 5) .The former argument is less compel-
ling, since it assumes that the activity catalyzed by plasma
membraneGLUT4 is at least comparable to that ofGLUTI .
While there are no direct measurements ofthe turnover num-
ber of GLUT4, a number of investigators have argued for
greater activity of this isoform at the concentrations of sub-
strate used in these experiments (9, 23, 27, 33) . If correct,
this would have the effect of making the deoxyglucose uptake
assay more sensitive to increased levels of cell surface
GLUT4 thanGLUTI . Nonetheless, the possibility exists that
other cellular proteins interact with and regulate the catalytic
activity of facilitated hexose carriers, thus preventing a sim-
ple extrapolation of transport activity to plasma membrane
carrier number (11) . It is of interest that expression of
GLUT4 in Xenopus oocytes in contrast to fibroblasts leads
to increased hexose uptake (Fig . 3) . Either the high level of
expression in the oocyte system saturates the endogenous
sorting pathways, or the oocyte does not completely recog-
nize the differences between the two transporter isoforms.
The immuno-localization data provide considerably more
convincing evidence for intrinsic targeting differences be-
tweenGLUTI andGLUT4 . These are unlikely to be a result
of a differential level of expression of the two isoforms .
Transfected and endogenous GLUTI displayed a subcellular
distribution distinct from that ofGLUT4, in spite ofthe fact
795that non-transfected NIH-3T3 fibroblasts and JGT2 cells ex-
press one third and five times, respectively, as much GLUTI
as there was GLUT4 in JSM8 cells. In visually scanning
polyclonal pools of GLUTI and GLUT4 expressing cells,
there was a reasonable consistency in the pattern of distribu-
tion of each of the isoforms among individual fibroblasts.
The exception to this was the rare cell expressing very high
levels of GLUT4, in which the isoform was also located on
the cell surface. The conclusion from these experiments is
that, in spite of the 65% amino acid sequence identity be-
tween GLUT1 and GLUT4, the two isoforms contain infor-
mation dictating distinct cellular trafficking pathways, and
that these signals can be recognized in nondifferentiated cell
types.
Addition of insulin to fibroblasts expressing GLUT4 pro-
tein did not augment hexose uptake to levels different than
parental, non-transfected fibroblasts (Fig. 2) . Moreover, co-
expression of functional insulin receptors in addition to
GLUT4 did not reconstitute true hormone-regulatable hex-
ose flux (Fig. 4) . The lack of effect ofthe number of insulin
receptors on the transport response is consistent with a
previous observation that, in the course of differentiation of
3T3-Ll adipocytes, the acquisition of augmented glucose
transport in response to maximal concentrations of insulin
precedes the appearance of additional hormone receptors
(15). Thus, the most simplistic interpretation of the data in
Fig. 4 is that other tissue-specific factors are required to con-
stitute the insulin-responsive differentiated phenotype. This
conclusion is strengthened by the fact that the ratio of
GLUT4 to GLUTI in JSM8 fibroblasts, ti3 :1, is considera-
bly higher than in authentically insulin-responsive 3T3-Ll
adipocytes, in which it is 1:3.5 to 1:5 (9, 33). The difficulty
with further interpretation of these experiments is that the
development of the hormone-sensitive phenotype is so com-
plex that it is impossible to infer the nature of the deficient
function. For example, in the course ofdifferentiation ofmu-
rine adipocytes, basal hexose uptake decreases substantially
(15); obviously, this has not been reproduced in the trans-
fected NIH-3T3 cells. Furthermore, it is unclear at present
whether the lack of augmented insulin-responsive deoxyglu-
cose uptake in JSM8 cells is a result of a decreased capacity
of GLUT4 to move to the plasma membrane in response to
insulin, an inability of GLUT4 to remain on the surface for
an appreciable length of time, or an insubstantial contribu-
tion of the GLUT4 isoform to the total transport activity.
Identification of the defective steps might suggest which
adipose-specific function is lacking in the transfected fibro-
blasts.
Having established that upon expression in fibroblasts
GLUT4 was targeted to a subcellular site distinct from
GLUT1, we sought to define the nature of the compartment
in which the former resided . Immuno-localization of endo-
cytic pathways by several independent strategiesrevealed the
presence of GLUT4 . The transferrin receptor, which was
chosen as a marker for early endosomes and to a lesser ex-
tent late endosomes and trans-Golgi network (38, 39),
demonstrated the most striking coincidence of labeling with
GLUT4. The mannose-6-phosphate receptor, which served
to identify late endosomal structures (18), also co-localized
with GLUT4 found in the perinuclear region. Taken to-
gether, these data indicate that GLUT4 is directed to all com-
ponents ofthe endocytic pathways. To obtain further support
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for this conclusion using an independent, dynamic marker
of endocytosis, cell surface glycoproteins were labeled by
the lectin, FITCWGA. The uptake of WGA into CHO
fibroblasts has been studied in some detail, and shown to be
mediated by a subpopulation ofmembrane proteins, the high
molecular weight acidic glycoproteins (34). WGA was rap-
idly internalized in CHO cells, entering the tubulo-vesicular
structures of the early and late endosomal pathway, as well
as recycling back to the cell surface (34). FITCWGA ap-
peared to behave in a similar manner in the experiments
reported above. At 2.5 min, it labeled peripheral structures
also detected by ot-GLUT4 (Fig. 10). At later times, the
FITCWGA moved to more centrally located structures, but
again co-localized with some of the GLUT4. Again, these
data are most consistent with the targeting of GLUT4 to en-
dosomal tubulovesicular structures. It is unlikely that FITC-
WGA influenced the trafficking ofGLUT4, since the general
pattern oftransporter immunoreactivity was unchanged. The
data presented herein do not distinguish whether GLUT4 is
transiently expressed on the cell surface or is targeted
directly to an early endosomal compartment. Though the
former seems more likely, proofawaits a method of labeling
cell surface GLUT4.
The distribution of GLUT4 in fibroblasts is reminiscent of
that of synaptophysin, a polytopic membrane-spanning pro-
tein residing in the small synaptic vesicles (SSV) of neuroen-
docrine cells (13) . The recycling of synaptophysin in neurons
in many ways resembles that of GLUT4 in adipocytes: both
are recruited to the plasma membrane in response to agonist,
and then follow an early endosomal pathway on their way
back to the "storage" compartment (13, 37) . Thus, it is strik-
ing that synaptophysin expressed in non-neuroendocrine
cells localized in a distribution very much resembling that
of GLUT4, concentrating in transferrin receptor-positive
vesicles (25, 28). A major question now outstanding is
whether the cellular location for GLUT4 in adipocytes is an
extension ofthe ubiquitous endosomal system, or a distinct,
tissue-specific organelle, perhaps analogous to small synap-
tic vesicles. Interestingly, when GLUT4 was expressed in the
neuronal-like cell line PC12, it co-localized with synap-
tophysin in endosomes, in which most of the synaptophysin
resided, but was excluded from small synaptic vesicles (Hud-
son, A. W., D. Fingar, and M . J. Birnbaum, unpublished ob-
servations).
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Note Added in Proof . A recentpublication (Haney, P. M., J. W. Slot, R. C.
Piper, D. E. James, and M. Mueckler. 1991 . J. Cell Biol. 114:689-699)
describing the subcellular localization of GLUT1 and GLUT4 expressed
in fibroblasts agrees in substance with the results reported herein.
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